Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung
Metastases are the main cause of death in cancer patients, and platelets are largely known for their contribution in cancer progression. However, targeting platelets is highly challenging given their paramount function in hemostasis. Using a high-throughput screening and platelet-induced breast tumo...
Main Authors: | Lou Saier, Johnny Ribeiro, Thomas Daunizeau, Audrey Houssin, Gabriel Ichim, Caroline Barette, Lamia Bouazza, Olivier Peyruchaud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/20/12221 |
Similar Items
-
Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR
by: Arman A. Sadybekov, et al.
Published: (2020-12-01) -
Deficiency of astrocyte CysLT1R ameliorates depression-like behaviors in mice by modulating glutamate synaptic transmission
by: Xiao Liu, et al.
Published: (2022-12-01) -
The role of leukotrienes in allergic diseases
by: Min Liu, et al.
Published: (2015-01-01) -
CysLT<sub>2</sub>R Antagonist HAMI 3379 Ameliorates Post-Stroke Depression through NLRP3 Inflammasome/Pyroptosis Pathway in Gerbils
by: Li Zhou, et al.
Published: (2022-07-01) -
CysLT2 receptor antagonist HAMI3379 inhibits LPS-induced inflammation in mice microglia line BV-2
by: GU Sheng-long, LI Ming-xing, YING Miao-fa, FANG San-hua, RAO Yue-feng, ZHAO Rui
Published: (2020-02-01)